The unfortunate reality is that COVID-19 might not be the last pandemic. The threat of the next pandemic will always be hanging over our heads—unless the world takes steps to prevent it. You can learn more about this topic in our 2021 Annual Letter at http://gatesnot.es/3a5KOLU
March 2020 began on a high note for American business and ended with the economy in tatters This WSJ documentary goes behind-the-scenes to reveal how the coronavirus pandemic ripped through American business during the month of March 2020 — told through the firsthand accounts of 12 prominent executives. When the coronavirus tore through industry, commerce and society in March 2020, the U.S. economy came to a screeching halt. Top executives relive the tough decisions they made as they scrambled to weather the storm. Photo Illustration: Adele Morgan/The Wall Street Journal
The covid-19 pandemic may have derailed the world in 2020, but a far deadlier disease has shaped human history for thousands of years. Malaria defeated armies, fuelled the slave trade and jump-started the modern environmental movement. How covid-19 hinders the fight against malaria: https://econ.st/3gAsfCj
The Los Angeles Lakers took home the NBA championship this week. But the close of the season also marked a big victory for the league itself. The NBA played its finals in a unique environment that came to be known as the bubble.
Players were frequently tested and social distancing was heavily enforced. And, the experiment worked. The NBA did not report a single positive coronavirus case from players or staff. Reporters Emma Court and Brandon Kochkodin describe how the league did it, and whether other organizations can replicate its success.
Through homemade maps, CityLab readers shared perspectives and stories from a world transformed by the coronavirus pandemic.
From the Wall Street Journal (June 8, 2020):
“We have to operate a hospital within a hospital, taking care of the needs for patients who have had strokes or a newborn delivery or need surgery while dealing with an otherwise healthy 35-year-old who picked up Covid-19 at a social event,” says James Linder, chief executive of Nebraska Medicine…
For instance, more hospitals are remotely triaging and registering patients before they even arrive. Clinicians can consult with patients from their home via telemedicine to help determine how sick they are and if they need to come to the ER at all. From there, admissions are made with as little contact with staff or other patients as possible.
Hospitals are rethinking how they operate in light of the Covid-19 pandemic—and preparing for a future where such crises may become a grim fact of life.
With the potential for resurgences of the coronavirus, and some scientists warning about outbreaks of other infectious diseases, hospitals don’t want to be caught flat-footed again. So, more of them are turning to new protocols and new technology to overhaul standard operating procedure, from the time patients show up at an emergency room through admission, treatment and discharge.
Originating during the Black Death of the Middle Ages, face coverings to protect against the transmission of disease are not just medical requirements; they’re now a fashion statement. Mark Phillips talks with medical historian Mark Honigsbaum (“The Pandemic Century”) about the purpose and style of facemasks.
Interview with Dr. Nicole Lurie on rapid vaccine development, including new tools to facilitate vaccine testing and manufacturing and persistent challenges.
The need to rapidly develop a vaccine against SARS-CoV-2 comes at a time of explosion in basic scientific understanding, including in areas such as genomics and structural biology, that is supporting a new era in vaccine development. Over the past decade, the scientific community and the vaccine industry have been asked to respond urgently to epidemics of H1N1 influenza, Ebola, Zika, and now SARS-CoV-2. An H1N1 influenza vaccine was developed relatively rapidly, largely because influenza-vaccine technology was well developed and key regulators had previously decided that vaccines made using egg- and cell-based platforms could be licensed under the rules used for a strain change. Although a monovalent H1N1 vaccine was not available before the pandemic peaked in the Northern Hemisphere, it was available soon afterward as a stand-alone vaccine and was ultimately incorporated into commercially available seasonal influenza vaccines.
Nicole Lurie is a strategic advisor to the CEO of the Coalition for Epidemic Preparedness Innovations. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.